Wyeth, Teva Persevere In Talks On Protonix Generic

Law360, New York (January 22, 2008, 12:00 AM EST) -- Teva Pharmaceutical Industries Ltd. announced on Tuesday that it has agreed to extend a standstill agreement with rivals Altana Pharma AG and Wyeth Pharmaceuticals Inc. while the companies work to settle a dispute over Teva's generic version of Altana's heartburn drug Protonix.

Teva announced the launch of its generic product, called pantoprazole, in December, but agreed not to ship the product for 30 days while it tried to work out a deal with Altana, which makes Protonix, and Wyeth, which markets it in the U.S....
To view the full article, register now.